Evidence map›Paper›PMID 42446835›Full record

ArticleTissue engineering and regenerative medicine2026

L-Ascorbic Acid 2-Phosphate-Releasing Poly(trimethylene carbonate) Increases Cell Proliferation and Collagen Production: A Novel Material for Pelvic Organ Prolapse Tissue Engineering.

Katri Ala-Mononen, Dirk Grijpma, Alexander Efimov, Saana Mustakoski, Kirsi Kuismanen, Susanna Miettinen, Reetta Sartoneva

Abstract read
In one paragraph

Article in Tissue engineering and regenerative medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katri Ala-MononenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland. katri.ala-mononen@tuni.fi.ORCID http://orcid.org/0009-0009-3130-5441
Dirk GrijpmaAdvanced Organ Bioengineering and Therapeutics, Department of BioEngineering Technologies, Techmed Centre, University of Twente, Enschede, The Netherlands.
Alexander EfimovFaculty of Engineering and Naturals Sciences, Tampere University, Tampere, Finland.
Saana MustakoskiFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Kirsi KuismanenDepartment of Obstetrics and Gynaecology, The Wellbeing Services County of Pirkanmaa, Tampere University Hospital, Tampere, Finland.
Susanna MiettinenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Reetta SartonevaFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Funding

Academy of Finland 312413Academy of Finland 320164Academy of Finland 339405Academy of Finland PREINState funding for university-level health research 1051/7333State funding for university-level health research 1051/7338State funding for university-level health research 1051/7344
6 · The paper itself

Abstract

backgroundPelvic organ prolapse (POP) occurs due to the weakening of the pelvic floor connective tissues and their decreased collagen content, leading to the descent of pelvic organs into or through vagina. Therefore, biodegradable materials designed to enhance collagen production could be a future option for POP treatment.

methodsHere, we studied novel L-ascorbic acid 2-phosphate (A2P)-releasing biodegradable poly(trimethylene carbonate) (PTMC) materials. The effects of varying A2P concentrations (0, 5 or 10 wt%) were evaluated regarding material characteristics, such as component release and mechanical and surface properties. Further, materials' effect on proliferation, collagen production and attachment of human vaginal stromal cells (hVSCs) and human adipose-derived stromal cells (hASCs) were analyzed during 14-day culture period.

resultsA2P-releasing PTMC had good handling characteristics and mechanical properties, such as high tensile and suture retention strength. Rapid, yet controlled release of A2P from the PTMC was observed in in vitro release studies. Our results demonstrate that A2P-releasing PTMC significantly increased the proliferation and total collagen content of both hVSCs and hASCs. Further, genetic expression of collagen types I (COL I) and III (COL III) significantly increased on A2P-releasing PTMC membranes, and extracellular COL I fibers were visible in cultures on PTMC5. Increased attachment and cell sheet formation were observed in both hVSC and hASC cultures on A2P-releasing PTMC, and A2P increased α-smooth muscle actin (α-SMA) expression in hASCs.

conclusionOur results indicate that A2P-releasing PTMC is a promising option for enhancing tissue regeneration in applications for POP tissue engineering.

Indexed as

Ascorbic AcidCollagenDioxanesPelvic Organ ProlapsePolymersTissue EngineeringCell ProliferationCells, CulturedFemaleHumansStromal CellsVaginaascorbate-2-phosphateAscorbic AcidCollagenDioxanesPolymerspolytrimethylene carbonateCollagenL-ascorbic acid 2-phosphatePelvic organ prolapsePoly(trimethylene carbonate)Tissue engineering

Identifiers

PMID42446835
PMCPMC13620002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.